Overview
Athernal Bio, a Cambridge, UK-based provider of targeted immunotherapies for cancer interception, received a grant of nearly £700k through Innovate UK’s Growth Catalyst – Investor Partnerships programme. Backers included existing investor Delin Ventures....See more
Website
https://www.athernalbio.com/Headquarters
Cambridge, UK
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
GBP 700,000 • Grant
Announced on 9/14/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.